Logo 5711 2.5/500
Pill imprint Logo 5711 2.5/500 has been identified as Glyburide and metformin hydrochloride 2.5 mg / 500 mg.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy.
Glyburide/metformin 2.5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Glyburide and metformin hydrochloride Images
- Imprint:
-
Logo 5711
2.5/500 - Strength:
- 2.5 mg / 500 mg
- Color:
- Orange
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- copovidone
crospovidone
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
magnesium silicate
titanium dioxide
FD&C Red No. 40
FD&C Yellow No. 6
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-5711
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5148 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Glyburide and Metformin Hydrochloride resources
- Glyburide/Metformin (Wolters Kluwer)
- glyburide and metformin (Cerner Multum)
- glyburide and metformin (Micromedex) - Includes Dosage Information
- Glyburide and Metformin (FDA)
- Glyburide/Metformin Hydrochloride (Wolters Kluwer)


